ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • ACR Convergence 2026
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Home » Meeting Abstracts » Pediatric Rheumatology Symposium 2017

Abstract Number: 57

Quantification of Dynamic MRI examinations in Juvenile Idiopathic Arthritis

Nikolay Tzaribachev1, Romiesa Hagoug2, Polymnia Louka3, Joyee Islam3, Mark Hinton3, Olga Kubassova4 and Mikael Boesen5, 1PRI - Pediatric Rheumatology Research Institute, Bad Bramstedt, Germany, 2Imaging, Image Analysis Group, London, United Kingdom, 3Image Analysis Group, London, United Kingdom, 4Image Analysis Group, Image Analysis Group, London, England, 5Radiology, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Frederiskberg, Denmark

Share on X (Twitter) Share on Facebook Share on LinkedIn Share on Email
Print

Meeting: Pediatric Rheumatology Symposium 2017

Keywords: Biomarkers, Juvenile idiopathic arthritis (JIA) and outcomes, MRI

Session Information

Date: Thursday, May 18, 2017

Title: Clinical and Therapeutic Poster Session

Session Type: Abstract Submissions

Session Time: 5:30PM-7:00PM

Background/Purpose: In chronic inflammatory conditions, the need for a more objective measurement of disease activity has been identified, where dynamic contrast enhanced (DCE) MRI as imaging biomarker has been studied in RA. In children with juvenile idiopathic arthritis (JIA) similar knowledge is very limited. The purpose was to compare treatment related changes of clinical scores in patients with JIA and automated DCE-MRI quantitative parameters analyzed with a dedicated software Dynamikatm also compared to clinical outcomes of the patients.

Methods: In patients with polyarticular JIA with insufficient (≥3 affected joints) response or intolerance to ≥3 months Methotrexate, Etanercept was started. Six Slice Axial DCE-MRI of the metacarpophaleangeal (MCP) 2-5 joints in the clinically most affected hand was performed at 3 time points: baseline (BL), month 3 and 6 of treatment using a 0.2 Tesla Esaote C-Scan. Clinical scores included active joint (AJ) counts. Clinical response was considered a state of ≤ 3 AJ. DCE-MRI was analyzed using regions of interest (ROI) covering synovium in slices where MCPs 2-5 were visible. Output parameters included dynamic MRI quantification scores (DEMRIQvol) corresponding to the volume of enhancing voxels within the synovial ROIs alone or multiplied with the mean of the maximum enhancement (ME) or the initial rate of enhancement (IRE) .

Differences in DEMRIQvol scores between visits were analyzed using t-test (p<0.05* = statistically significant, p<0.25** = clinically meaningful). Concordance between clinical and DEMRIQvol scores were described.

Results: 18 Caucasian patients (12 girls, median age 12,6 years, median disease duration 1,2 years) were included in the study. Two patients discontinued imaging after BL but continued treatment. In all but 3 of the remaining patients statistically significant and/or clinically meaningful changes were documented for DEMRIQ ME between visits.

In 4 patients clinical and DEMRIQvol scores showed corresponded changes. In all other patients clinical and DEMRIQvol scores were non-concordant.

Based on DEMRIQvol change (irrespective of the clinical scores) the outcome of the patient could be predicted:

  • in 5 patients improvement of DEMRIQvol scores predicted response to treatment (within 2-6 months after last MRI examination)
  • in 4 patients an increase or persistence of a high DEMRIQvol predicted non-response to treatment
  • in 7 patients increase in DEMRIQvol (after initial decrease) or persistence of a high DEMRIQvol predicted flare (in 3 of the patients flare occurred after treatment discontinuation)

In all patients subclinical disease could be detected on MRI in clinically unaffected joints.

Conclusion: Dynamika based scores appear to be useful for depicting disease activity in JIA and seem to support clinical examination by detecting subclinical inflammation. More over, in the present study DEMRIQvol scores were predictive for the outcome of the patients and were able to “foresee” response to treatment, flare of disease, non-response to treatment in most patients possibly making DEMRIQvol scores supportive in research and clinical decision taking.



Disclosure: N. Tzaribachev, None; R. Hagoug, 3; P. Louka, 3; J. Islam, 3; M. Hinton, 3; O. Kubassova, 3; M. Boesen, 6.

To cite this abstract in AMA style:

Tzaribachev N, Hagoug R, Louka P, Islam J, Hinton M, Kubassova O, Boesen M. Quantification of Dynamic MRI examinations in Juvenile Idiopathic Arthritis [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 4). https://acrabstracts.org/abstract/quantification-of-dynamic-mri-examinations-in-juvenile-idiopathic-arthritis/. Accessed .

ACR Meeting Abstracts - https://acrabstracts.org/abstract/quantification-of-dynamic-mri-examinations-in-juvenile-idiopathic-arthritis/

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology